HSK39297 Tablet

HSK39297 · Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HSK39297 Tablet, covering 2024-11-01 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN [Phase 3]